The effect of regular caffeine consumption and caffeine withdrawal on the desire for caffeinated drinks
| ISRCTN | ISRCTN13021878 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN13021878 |
| Sponsor | University of Sussex |
| Funder | Biotechnology and Biological Sciences Research Council |
- Submission date
- 15/09/2026
- Registration date
- 16/09/2026
- Last edited
- 16/09/2026
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Other
Plain English summary of protocol
Background and study aims
Many people drink coffee regularly and become dependent on it, but it is unclear what motivates this behaviour. This study explored two theories that may explain coffee consumption: negative reinforcement (motivated by relief from unpleasant symptoms such as tiredness) and Incentive Sensitisation Theory (motivated by an increased urge or “wanting”).
Who can participate?
Healthy volunteers aged 18 - 50 years
What does the study involve?
Participants were screened and recruited into two groups: high (more than two cups of coffee a day) and low (less than one cup of coffee a day) coffee consumers. The study involved two laboratory-based test sessions that were conducted on separate days at least a week apart, where the participant was given either caffeine (100 mg) or placebo dissolved in and consumed as a lemon and ginger tea.
What are the possible benefits and risks of participating?
Participants were rewarded with cash or University course credits for taking part and the risks for participating were negligible.
Where is the study run from?
University of Sussex (UK)
When is the study starting and how long is it expected to run for?
February 2024 to July 2026
Who is funding the study?
Biotechnology and Biological Sciences Research Council (BBSRC) (UK)
Who is the main contact?
1. Tatum Sevenoaks, T.Sevenoaks@sussex.ac.uk
2. Martin Yeomans, martin@sussex.ac.uk
Contact information
Principal investigator
Falmer
Brighton
BN1 9RH
United Kingdom
| Phone | +44 (0)1273678617 |
|---|---|
| martin@sussex.ac.uk |
Scientific, Public
Falmer
Brighton
BN1 9RH
United Kingdom
| Phone | +44 (0)7384506522 |
|---|---|
| T.Sevenoaks@sussex.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Allocation | Randomized controlled trial |
| Masking | Blinded (masking used) |
| Control | Placebo |
| Assignment | Crossover |
| Purpose | Basic science |
| Scientific title | Effects of habitual caffeine consumption and caffeine deprivation on ‘wanting’ and ‘liking’ for caffeinated drinks |
| Study objectives | The primary objective of this study was to investigate explicit and implicit 'wanting' and 'liking' for coffee controlling for acute caffeine deprivation. |
| Ethics approval(s) |
Approved 01/02/2024, University of Sussex Sciences and Technology Research Ethics Committee (Falmer, Brighton, BN1 9RH, United Kingdom; +44 (0)1273606755; frecsemset@sussex.ac.uk), ref: ER/TS580/9 |
| Health condition(s) or problem(s) studied | Habitual coffee consumption |
| Intervention | The study implemented a randomised double-blind placebo controlled crossover design. Participants were screened and recruited into two groups: high (>2 cups of coffee a day) and low (<1 cup of coffee a day) coffee consumers. The study involved two laboratory-based test sessions that were conducted on separate days at least a week apart, where the participant was given either caffeine (100 mg) or placebo dissolved in and consumed as a lemon and ginger tea. A double-blind procedure was implemented so that neither the participants nor the researcher knew whether caffeine or placebo was administered to the participant during the testing session. The order of the caffeine and placebo conditions was randomised using a computer-generated randomisation schedule by a faculty member external to this study, who also ensured that caffeine or placebo was stored in distinct sealed containers for each study session. |
| Intervention type | Drug |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Caffeine |
| Primary outcome measure(s) |
|
| Key secondary outcome measure(s) |
|
| Completion date | 14/07/2026 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 50 Years |
| Sex | All |
| Target sample size at registration | 64 |
| Total final enrolment | 64 |
| Key inclusion criteria | Healthy volunteers |
| Key exclusion criteria | 1. Those who smoke more than 5 cigarettes per week or vaped 2. Those taking prescription medication other than the oral contraceptive pill 3. Those who are diabetic 4. Did not drink coffee |
| Date of first enrolment | 27/02/2024 |
| Date of final enrolment | 16/10/2025 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Falmer
Southern Ring Road
Brighton
BN1 9RH
England
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|
Editorial Notes
15/09/2026: Study's existence confirmed by the University of Sussex Sciences and Technology Research Ethics Committee.